(VIANEWS) – Knowles Corporation (KN), Navios Maritime Partners LP (NMM), Stantec (STN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Knowles Corporation (KN)
23% sales growth and 7.93% return on equity
Knowles Corporation designs, manufactures, and sells micro-acoustic, audio processing, and precision device solutions for the mobile consumer electronics, communications, medtech, defense, automotive, and industrial markets worldwide. It operates in two segments, Audio and Precision Devices (PD). The Audio segment designs and manufactures audio products, including microphones and balanced armature speakers, audio processors, and software and algorithms used in applications that serve the mobile, ear, and Internet of Things markets. The PD segment designs and delivers capacitor products and radio frequency solutions that are used in applications, such as power supplies and medical implants, satellite communication, and radar systems, as well as our telecommunications infrastructure customers. The company also provides single layer electronic components to the telecommunication, fiber optics, and defense markets. It sells its products directly to original equipment manufacturers and to their contract manufacturers and suppliers, as well as through distributors. The company was founded in 1946 and is headquartered in Itasca, Illinois.
Earnings Per Share
As for profitability, Knowles Corporation has a trailing twelve months EPS of $0.88.
PE Ratio
Knowles Corporation has a trailing twelve months price to earnings ratio of 19.32. Meaning, the purchaser of the share is investing $19.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.93%.
Volume
Today’s last reported volume for Knowles Corporation is 204989 which is 65.06% below its average volume of 586793.
Revenue Growth
Year-on-year quarterly revenue growth grew by 36.1%, now sitting on 759.7M for the twelve trailing months.
2. Navios Maritime Partners LP (NMM)
16.7% sales growth and 15.44% return on equity
Navios Maritime Partners L.P. owns and operates dry cargo vessels in Asia, Europe, North America, and Australia. The company offers seaborne transportation services for a range of liquid and dry cargo commodities, including crude oil, refined petroleum, chemicals, iron ore, coal, grain, fertilizer, and containers, as well as charters its vessels under short, medium, and longer-term charters. Olympos Maritime Ltd. serves as the general partner of Navios Maritime Partners L.P. The company was founded in 2007 and is based in Monaco.
Earnings Per Share
As for profitability, Navios Maritime Partners LP has a trailing twelve months EPS of $13.24.
PE Ratio
Navios Maritime Partners LP has a trailing twelve months price to earnings ratio of 3.96. Meaning, the purchaser of the share is investing $3.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.44%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Feb 9, 2024, the estimated forward annual dividend rate is 0.2 and the estimated forward annual dividend yield is 0.38%.
Yearly Top and Bottom Value
Navios Maritime Partners LP’s stock is valued at $52.42 at 16:22 EST, under its 52-week high of $53.83 and way higher than its 52-week low of $20.92.
3. Stantec (STN)
13.3% sales growth and 13.32% return on equity
Stantec Inc. provides professional services in the areas of infrastructure and facilities to the public and private sectors in Canada, the United States, and internationally. It offers evaluation, planning, and designing infrastructure solutions; solutions for sustainable water resources, planning, management, and infrastructure; environmental services; integrated architecture, engineering, interior design, and planning solutions for buildings; and energy and resources solutions. The company also provides consulting services in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics. In addition, it offers planning and design services to clients in residential, logistics, retail, infrastructure, energy, higher education, and urban regeneration sectors; architectural and interior design, and planning services in the science and technology, commercial workplace, higher education, residential, and hospitality markets. Further, the company provides transportation advisory, transport engineering, and technical design; project delivery consultancy services for mining, resources, and industrial infrastructure projects; paleontological and archaeological services for the rail, transportation, water, and power and energy sectors; and environmental and cultural resource compliance services. Additionally, it offers consulting services in sustainable building design, energy infrastructure upgrades, sustainable district heating network, and e-mobility; and planning, design, construction administration, commissioning, maintenance, decommissioning, and remediation services. The company was formerly known as Stanley Technology Group Inc. and changed its name to Stantec Inc. in October 1998. Stantec Inc. was founded in 1954 and is headquartered in Edmonton, Canada.
Earnings Per Share
As for profitability, Stantec has a trailing twelve months EPS of $2.25.
PE Ratio
Stantec has a trailing twelve months price to earnings ratio of 36.76. Meaning, the purchaser of the share is investing $36.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.32%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.5%, now sitting on 5.21B for the twelve trailing months.
Sales Growth
Stantec’s sales growth is 18.8% for the current quarter and 13.3% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 12.5% and 9.4%, respectively.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 27, 2024, the estimated forward annual dividend rate is 0.62 and the estimated forward annual dividend yield is 0.74%.
4. Grifols, S.A. (GRFS)
8.1% sales growth and 3.48% return on equity
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuum–from prevention, screening, diagnosis, and prognosis to disease and treatment monitoring–to serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.
Earnings Per Share
As for profitability, Grifols, S.A. has a trailing twelve months EPS of $0.1.
PE Ratio
Grifols, S.A. has a trailing twelve months price to earnings ratio of 70. Meaning, the purchaser of the share is investing $70 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.48%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 6.66B for the twelve trailing months.
Yearly Top and Bottom Value
Grifols, S.A.’s stock is valued at $7.00 at 16:22 EST, way under its 52-week high of $12.15 and way higher than its 52-week low of $5.30.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 53.3% and 100%, respectively.
5. Merit Medical Systems (MMSI)
6.7% sales growth and 8.45% return on equity
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm management, and hemodynamic monitoring to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, swab and collection systems, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, advanced over-the-wire and direct visualization delivery systems, and dilation balloons; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Earnings Per Share
As for profitability, Merit Medical Systems has a trailing twelve months EPS of $1.74.
PE Ratio
Merit Medical Systems has a trailing twelve months price to earnings ratio of 47.25. Meaning, the purchaser of the share is investing $47.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.45%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.7%, now sitting on 1.28B for the twelve trailing months.
Yearly Top and Bottom Value
Merit Medical Systems’s stock is valued at $82.21 at 16:22 EST, below its 52-week high of $85.18 and way above its 52-week low of $62.58.
Volume
Today’s last reported volume for Merit Medical Systems is 514951 which is 50.61% above its average volume of 341908.
Moving Average
Merit Medical Systems’s worth is above its 50-day moving average of $79.07 and way higher than its 200-day moving average of $74.27.
6. Immersion Corporation (IMMR)
5.8% sales growth and 24.16% return on equity
Immersion Corporation, together with its subsidiaries, creates, designs, develop, and licenses haptic technologies that allow people to use their sense of touch to engage with and experience various digital products in North America, Europe, and Asia. The company provides technology, patent, and combined licenses. It also provides software development kits (SDKs) comprising tools, integration software, and effect libraries that allow for the design, encoding, and playback of tactile effects. In addition, the company offers reference designs and reference technology, engineering and integration services, and software and firmware services. It serves mobile communications, wearables, and consumer electronics; gaming and virtual reality (VR); automotive; and other markets. Immersion Corporation was incorporated in 1993 and is headquartered in Aventura, Florida.
Earnings Per Share
As for profitability, Immersion Corporation has a trailing twelve months EPS of $1.38.
PE Ratio
Immersion Corporation has a trailing twelve months price to earnings ratio of 7.45. Meaning, the purchaser of the share is investing $7.45 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.16%.
